Precision Immunotherapy

Immunotherapy is a type of treatment that helps the body’s immune system fight cancer. Several kinds of immunotherapy, including immune checkpoint inhibitors, adoptive cell transfer, and therapeutic vaccines are either commercially available or in clinical development. To date, six immune checkpoint inhibitors have been approved by FDA for the treatment of eight types of cancer. One of the inhibitors has also been approved to treat any solid tumour that has a specific genetic feature. This was the first FDA approval of its kind and a major advance for precision cancer medicine, in which the molecular characteristics of a tumour are used to identify effective therapies.

  • adoptive cell transfer
  • clinical development
  • molecular characteristics of a tumour

Related Conference of Precision Immunotherapy

November 21-22, 2025

5th International Conference on Medical Research and Development

Amsterdam, Netherlands
November 25-26, 2025

21st World Summit on Blockchain Technology

Amsterdam, Netherlands
February 04-05, 2026

18th International Conference on Gynecology

Rome, Italy
February 25-26, 2026

15th International Conference on Herbal Medicine and Acupuncture

Aix-en-Provence, France
March 09-10, 2026

13th World Machine Learning and Deep learning Conference

Singapore City, Singapore
March 26-27, 2026

12th World Congress on Anesthesia and Critical Care

Amsterdam, Netherlands
April 20-21, 2026

47th International Summit on Human Anatomy & Physiology

Barcelona, Spain
October 19-20, 2026

12th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France

Precision Immunotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in